{"text": ["Why", "AbbVie", "(ABBV)", "is", "a", "Top", "Dividend", "Stock", "for", "Your", "Portfolio"], "created_at": "2020-06-26 15:45:03"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "Chiasma,", "Heron", "Await", "FDA", "Decisions,", "DBV", "Restructures,", "3", "Biopharmas", "Make", "Wall", "Street", "Debuts"], "created_at": "2020-06-26 12:28:34"}
{"text": ["AbbVie's", "Eye", "Disorder", "Candidate", "Gets", "Complete", "Response", "Letter"], "created_at": "2020-06-26 12:25:12"}
{"text": ["How", "gene", "therapy", "and", "CRISPR", "are", "helping", "to", "cure", "blindness"], "created_at": "2020-06-26 12:21:00"}
{"text": ["Allergan,", "an", "AbbVie", "Company,", "and", "Molecular", "Partners", "Receive", "Complete", "Response", "Letter", "from", "FDA", "on", "Biologics", "License", "Application", "for", "Abicipar", "pegol"], "created_at": "2020-06-26 05:15:00"}
